SOURALOVÁ, Tereza, Katarína ČIMBOROVÁ, Vendula PELKOVÁ, Aleš HAMPL and Irena KOUTNÁ. Quality Control of Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cells for Regenerative Therapy. In XV. mezinárodní konferenci Bioimplantologie a regenerativní medicína, Lednice. 2024. ISBN 978-80-01-07293-6.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Quality Control of Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cells for Regenerative Therapy
Authors SOURALOVÁ, Tereza, Katarína ČIMBOROVÁ, Vendula PELKOVÁ, Aleš HAMPL and Irena KOUTNÁ.
Edition XV. mezinárodní konferenci Bioimplantologie a regenerativní medicína, Lednice, 2024.
Other information
Original language English
Type of outcome Conference abstract
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
ISBN 978-80-01-07293-6
Tags International impact
Changed by Changed by: Mgr. Tereza Souralová, učo 424163. Changed: 29/4/2024 09:52.
Abstract
Human retinal pigment epithelial (RPE) cells form a monolayer of polarized pigmented epithelial cells located between the blood vessels of the eye and the neural retina. The key function of RPE cells is the maintenance and protection of light-sensitive photoreceptors. Degeneration of RPE cells accompanies age-related eye diseases and can lead to the loss of vision. The rescue of the patient´s vision can be achieved by the replacement of the RPE cells. Therefore, we aim to differentiate human embryonal stem cells and human induced pluripotent stem cells into fully functional RPE cells that would be suitable for regenerative therapy. To ensure the RPE cells are not released for the treatment of the patient until the quality has been considered satisfactory, we designed a panel of quality control tests that characterize a) functionality: phagocytosis, specific cytokine secretion, b) morphology, c) identity and viability: marker detection by immunocytochemistry and flowcytometry, d) immunogenicity: lymphocyte-graft cell immune reaction, HLA expression of RPE cells. These tests are prepared for translation into advanced therapy medicinal product (ATMP) manufacture according to good manufacturing practice (GMP).
Links
LM2023049, research and development projectName: Český národní uzel Evropské sítě infrastruktur klinického výzkumu
Investor: Ministry of Education, Youth and Sports of the CR
NU22-08-00629, research and development projectName: Vývoj postupů pro léčbu makulární degenerace sítnice deriváty lidských pluripotentních kmenových buněk
Investor: Ministry of Health of the CR, Subprogram 1 - standard
PrintDisplayed: 30/7/2024 15:18